Ardent Health Inc. (ARDT) — Financial statements
Income statement, balance sheet, and cash flow for Ardent Health Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 6,324↑6.0% | 5,966↑10.3% | 5,409↑5.5% | 5,130↑5.3% | 4,870 | |
| Cost of Revenue | 156↓84.9% | 1,033↑633.5% | 141↓85.3% | 955↑3.0% | 927 | |
| Gross Profit | 6,169↑25.0% | 4,933↓6.4% | 5,269↑26.2% | 4,175↑5.9% | 3,943 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 1,193↓69.3% | 3,885↑7.7% | 3,608↑7.0% | 3,372↑7.6% | 3,132 | |
| Selling & Marketing Expenses | 0.00 | 0.00↓100.0% | 15 | 0.00 | 0.00 | |
| SG&A Expenses | 1,193↓69.3% | 3,885↑7.2% | 3,623↑7.4% | 3,372↑7.6% | 3,132 | |
| Other Expenses | 4,650↑623.8% | 643↓54.6% | 1,417↑141.8% | 586↑56.6% | 374 | |
| Operating Expenses | 5,843↑29.1% | 4,527↓10.2% | 5,039↑27.3% | 3,957↑12.9% | 3,507 | |
| Total Costs & Expenses | 5,999↑7.9% | 5,560↑7.3% | 5,180↑5.4% | 4,913↑10.8% | 4,434 | |
| Operating Results | ||||||
| Operating Income | 326↓19.8% | 406↑76.8% | 230↑5.7% | 217↓50.3% | 437 | |
| Depreciation & Amortization | 156↑6.4% | 146↑3.9% | 141↑1.9% | 138↑0.7% | 137 | |
| EBITDA | 481↓16.3% | 575↑64.3% | 350↓34.2% | 532↑0.9% | 527 | |
| EBIT | 326↓24.0% | 429↑104.9% | 209↓46.9% | 394↑1.0% | 390 | |
| Interest & Other Income | ||||||
| Net Interest Income | -55↑15.8% | -66↓0.2% | -65↑20.3% | -82↑12.6% | -94 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 55↓15.8% | 66↑0.2% | 65↓20.3% | 82↓12.6% | 94 | |
| Non-Operating Income | 0.00↑100.0% | -23↓212.4% | 20↑111.5% | -177↓476.8% | 47 | |
| Other Income / Expenses | -39↑8.1% | -43↑45.2% | -78↓182.5% | 94↑167.1% | -141 | |
| Income Before Tax | 286↓21.1% | 363↑139.5% | 152↓51.3% | 311↑5.3% | 296 | |
| Income Tax Expense | 56↓11.3% | 63↑179.9% | 23↓50.9% | 46↓10.1% | 51 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 230↓23.2% | 300↑132.4% | 129↓51.4% | 265↑8.5% | 245 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 136↓35.4% | 210↑318.2% | 50↓73.4% | 189↑22.5% | 154 | |
| Bottom-Line Net Income | 136↓35.4% | 210↑318.2% | 50↓73.4% | 189↑22.5% | 154 | |
| EPS (Basic) | 0.96↓39.6% | 1.59↑354.3% | 0.35↓73.5% | 1.32↑22.2% | 1.08 | |
| EPS (Diluted) | 0.96↓39.2% | 1.58↑351.4% | 0.35↓73.5% | 1.32↑22.2% | 1.08 | |
| Weighted Average Shares | 141↑6.3% | 132↓7.6% | 143↑0.0% | 143↑0.0% | 143 | |
| Weighted Average Diluted Shares | 141↑6.6% | 133↓7.3% | 143↑0.0% | 143↑0.0% | 143 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.